USA Human Growth Hormone Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • HGH, produced by the pituitary gland, spurs growth in children and adolescents. It also helps to regulate body composition, body fluids, muscle and bone growth, sugar and fat metabolism, and possibly heart function. Produced synthetically, HGH is the active ingredient in a number of prescription drugs and in other products available widely over the Internet.

    Human growth hormone is a peptide hormone, stimulating growth in children and adolescents, and is produced by the pituitary gland. It helps in the growth of bones and muscles by specific cellular differentiation. Apart from stimulating growth, the human growth hormone also regulates carbohydrate metabolism, protein metabolism and fat metabolism. Moreover, the usage of human growth hormone drugs in growth hormone deficient patient has shown significant positive results on the patient’s working capacity, mental alertness and memory. The over secretion of growth hormone leads to gigantism and its deficiency causes dwarfism. The human growth hormone drugs are developed and manufactured by recombinant DNA technology. Earlier, these drugs were mostly used as replacement therapy in pediatric and adult patients, having the deficiency of growth hormones. However, the technological advancements and increased research and development in growth hormone drugs, have resulted in the development of anti-aging drugs and performance enhancers.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Human Growth Hormone Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Human Growth Hormone Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Human Growth Hormone Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Novo Nordisk A/S (Denmark)

    • Ferring Holding SA (Switzerland)

    • GeneScience Pharmaceuticals Co, Ltd (China)

    • Genentech, Inc (US)

    • Pfizer, Inc (US)

    • Sandoz International GmbH (Germany)

    • Eli Lilly and Company (US)

    • Merck KgaA (Germany)

    By Type:

    • Norditropin

    • Genotropin

    • Humatrope

    • Saizen

    • Omnitrope

    • Somatropin Biopartners

    By End-User:

    • Prader-Willi Syndrome

    • Turner Syndrome

    • Short Stature Homeobox Gene

    • Small for Gestational Age

    • Chronic Renal Insufficiency

    • Short Bowel Syndrome

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Growth Hormone Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Human Growth Hormone Drugs Market Size and Growth Rate of Norditropin from 2016 to 2027

      • 1.3.2 USA Human Growth Hormone Drugs Market Size and Growth Rate of Genotropin from 2016 to 2027

      • 1.3.3 USA Human Growth Hormone Drugs Market Size and Growth Rate of Humatrope from 2016 to 2027

      • 1.3.4 USA Human Growth Hormone Drugs Market Size and Growth Rate of Saizen from 2016 to 2027

      • 1.3.5 USA Human Growth Hormone Drugs Market Size and Growth Rate of Omnitrope from 2016 to 2027

      • 1.3.6 USA Human Growth Hormone Drugs Market Size and Growth Rate of Somatropin Biopartners from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Human Growth Hormone Drugs Market Size and Growth Rate of Prader-Willi Syndrome from 2016 to 2027

      • 1.4.2 USA Human Growth Hormone Drugs Market Size and Growth Rate of Turner Syndrome from 2016 to 2027

      • 1.4.3 USA Human Growth Hormone Drugs Market Size and Growth Rate of Short Stature Homeobox Gene from 2016 to 2027

      • 1.4.4 USA Human Growth Hormone Drugs Market Size and Growth Rate of Small for Gestational Age from 2016 to 2027

      • 1.4.5 USA Human Growth Hormone Drugs Market Size and Growth Rate of Chronic Renal Insufficiency from 2016 to 2027

      • 1.4.6 USA Human Growth Hormone Drugs Market Size and Growth Rate of Short Bowel Syndrome from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Human Growth Hormone Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Human Growth Hormone Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Human Growth Hormone Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Human Growth Hormone Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Human Growth Hormone Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Human Growth Hormone Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Norditropin

      • 3.4.2 Market Size and Growth Rate of Genotropin

      • 3.4.3 Market Size and Growth Rate of Humatrope

      • 3.4.4 Market Size and Growth Rate of Saizen

      • 3.4.5 Market Size and Growth Rate of Omnitrope

      • 3.4.6 Market Size and Growth Rate of Somatropin Biopartners

    4 Segmentation of Human Growth Hormone Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Human Growth Hormone Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Human Growth Hormone Drugs in Prader-Willi Syndrome

      • 4.4.2 Market Size and Growth Rate of Human Growth Hormone Drugs in Turner Syndrome

      • 4.4.3 Market Size and Growth Rate of Human Growth Hormone Drugs in Short Stature Homeobox Gene

      • 4.4.4 Market Size and Growth Rate of Human Growth Hormone Drugs in Small for Gestational Age

      • 4.4.5 Market Size and Growth Rate of Human Growth Hormone Drugs in Chronic Renal Insufficiency

      • 4.4.6 Market Size and Growth Rate of Human Growth Hormone Drugs in Short Bowel Syndrome

    5 Market Analysis by Regions

    • 5.1 USA Human Growth Hormone Drugs Production Analysis by Regions

    • 5.2 USA Human Growth Hormone Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Human Growth Hormone Drugs Landscape Analysis

    • 6.1 West USA Human Growth Hormone Drugs Landscape Analysis by Major Types

    • 6.2 West USA Human Growth Hormone Drugs Landscape Analysis by Major End-Users

    7 South USA Human Growth Hormone Drugs Landscape Analysis

    • 7.1 South USA Human Growth Hormone Drugs Landscape Analysis by Major Types

    • 7.2 South USA Human Growth Hormone Drugs Landscape Analysis by Major End-Users

    8 Middle West USA Human Growth Hormone Drugs Landscape Analysis

    • 8.1 Middle West USA Human Growth Hormone Drugs Landscape Analysis by Major Types

    • 8.2 Middle West USA Human Growth Hormone Drugs Landscape Analysis by Major End-Users

    9 Northeast USA Human Growth Hormone Drugs Landscape Analysis

    • 9.1 Northeast USA Human Growth Hormone Drugs Landscape Analysis by Major Types

    • 9.2 Northeast USA Human Growth Hormone Drugs Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Novo Nordisk A/S (Denmark)

        • 10.1.1 Novo Nordisk A/S (Denmark) Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Ferring Holding SA (Switzerland)

        • 10.2.1 Ferring Holding SA (Switzerland) Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 GeneScience Pharmaceuticals Co, Ltd (China)

        • 10.3.1 GeneScience Pharmaceuticals Co, Ltd (China) Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Genentech, Inc (US)

        • 10.4.1 Genentech, Inc (US) Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Pfizer, Inc (US)

        • 10.5.1 Pfizer, Inc (US) Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Sandoz International GmbH (Germany)

        • 10.6.1 Sandoz International GmbH (Germany) Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Eli Lilly and Company (US)

        • 10.7.1 Eli Lilly and Company (US) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Merck KgaA (Germany)

        • 10.8.1 Merck KgaA (Germany) Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Norditropin from 2016 to 2027

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Genotropin from 2016 to 2027

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Humatrope from 2016 to 2027

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Saizen from 2016 to 2027

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Omnitrope from 2016 to 2027

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Somatropin Biopartners from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Prader-Willi Syndrome from 2016 to 2027

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Turner Syndrome from 2016 to 2027

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Short Stature Homeobox Gene from 2016 to 2027

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Small for Gestational Age from 2016 to 2027

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Chronic Renal Insufficiency from 2016 to 2027

    • Figure USA Human Growth Hormone Drugs Market Size and Growth Rate of Short Bowel Syndrome from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Human Growth Hormone Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Human Growth Hormone Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Human Growth Hormone Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Human Growth Hormone Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Human Growth Hormone Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Human Growth Hormone Drugs

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Human Growth Hormone Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of Human Growth Hormone Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Norditropin

    • Figure Market Size and Growth Rate of Genotropin

    • Figure Market Size and Growth Rate of Humatrope

    • Figure Market Size and Growth Rate of Saizen

    • Figure Market Size and Growth Rate of Omnitrope

    • Figure Market Size and Growth Rate of Somatropin Biopartners

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Human Growth Hormone Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of Human Growth Hormone Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Prader-Willi Syndrome

    • Figure Market Size and Growth Rate of Turner Syndrome

    • Figure Market Size and Growth Rate of Short Stature Homeobox Gene

    • Figure Market Size and Growth Rate of Small for Gestational Age

    • Figure Market Size and Growth Rate of Chronic Renal Insufficiency

    • Figure Market Size and Growth Rate of Short Bowel Syndrome

    • Table USA Human Growth Hormone Drugs Production by Regions

    • Table USA Human Growth Hormone Drugs Production Share by Regions

    • Figure USA Human Growth Hormone Drugs Production Share by Regions in 2016

    • Figure USA Human Growth Hormone Drugs Production Share by Regions in 2021

    • Figure USA Human Growth Hormone Drugs Production Share by Regions in 2027

    • Table USA Human Growth Hormone Drugs Consumption by Regions

    • Table USA Human Growth Hormone Drugs Consumption Share by Regions

    • Figure USA Human Growth Hormone Drugs Consumption Share by Regions in 2016

    • Figure USA Human Growth Hormone Drugs Consumption Share by Regions in 2021

    • Figure USA Human Growth Hormone Drugs Consumption Share by Regions in 2027

    • Table West USA Human Growth Hormone Drugs Consumption by Types from 2016 to 2027

    • Table West USA Human Growth Hormone Drugs Consumption Share by Types from 2016 to 2027

    • Figure West USA Human Growth Hormone Drugs Consumption Share by Types in 2016

    • Figure West USA Human Growth Hormone Drugs Consumption Share by Types in 2021

    • Figure West USA Human Growth Hormone Drugs Consumption Share by Types in 2027

    • Table West USA Human Growth Hormone Drugs Consumption by End-Users from 2016 to 2027

    • Table West USA Human Growth Hormone Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Human Growth Hormone Drugs Consumption Share by End-Users in 2016

    • Figure West USA Human Growth Hormone Drugs Consumption Share by End-Users in 2021

    • Figure West USA Human Growth Hormone Drugs Consumption Share by End-Users in 2027

    • Table South USA Human Growth Hormone Drugs Consumption by Types from 2016 to 2027

    • Table South USA Human Growth Hormone Drugs Consumption Share by Types from 2016 to 2027

    • Figure South USA Human Growth Hormone Drugs Consumption Share by Types in 2016

    • Figure South USA Human Growth Hormone Drugs Consumption Share by Types in 2021

    • Figure South USA Human Growth Hormone Drugs Consumption Share by Types in 2027

    • Table South USA Human Growth Hormone Drugs Consumption by End-Users from 2016 to 2027

    • Table South USA Human Growth Hormone Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Human Growth Hormone Drugs Consumption Share by End-Users in 2016

    • Figure South USA Human Growth Hormone Drugs Consumption Share by End-Users in 2021

    • Figure South USA Human Growth Hormone Drugs Consumption Share by End-Users in 2027

    • Table Middle West USA Human Growth Hormone Drugs Consumption by Types from 2016 to 2027

    • Table Middle West USA Human Growth Hormone Drugs Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Human Growth Hormone Drugs Consumption Share by Types in 2016

    • Figure Middle West USA Human Growth Hormone Drugs Consumption Share by Types in 2021

    • Figure Middle West USA Human Growth Hormone Drugs Consumption Share by Types in 2027

    • Table Middle West USA Human Growth Hormone Drugs Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Human Growth Hormone Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Human Growth Hormone Drugs Consumption Share by End-Users in 2016

    • Figure Middle West USA Human Growth Hormone Drugs Consumption Share by End-Users in 2021

    • Figure Middle West USA Human Growth Hormone Drugs Consumption Share by End-Users in 2027

    • Table Northeast USA Human Growth Hormone Drugs Consumption by Types from 2016 to 2027

    • Table Northeast USA Human Growth Hormone Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Human Growth Hormone Drugs Consumption Share by Types in 2016

    • Figure Northeast USA Human Growth Hormone Drugs Consumption Share by Types in 2021

    • Figure Northeast USA Human Growth Hormone Drugs Consumption Share by Types in 2027

    • Table Northeast USA Human Growth Hormone Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Human Growth Hormone Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Human Growth Hormone Drugs Consumption Share by End-Users in 2016

    • Figure Northeast USA Human Growth Hormone Drugs Consumption Share by End-Users in 2021

    • Figure Northeast USA Human Growth Hormone Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Novo Nordisk A/S (Denmark)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk A/S (Denmark)

    • Figure Sales and Growth Rate Analysis of Novo Nordisk A/S (Denmark)

    • Figure Revenue and Market Share Analysis of Novo Nordisk A/S (Denmark)

    • Table Product and Service Introduction of Novo Nordisk A/S (Denmark)

    • Table Company Profile and Development Status of Ferring Holding SA (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring Holding SA (Switzerland)

    • Figure Sales and Growth Rate Analysis of Ferring Holding SA (Switzerland)

    • Figure Revenue and Market Share Analysis of Ferring Holding SA (Switzerland)

    • Table Product and Service Introduction of Ferring Holding SA (Switzerland)

    • Table Company Profile and Development Status of GeneScience Pharmaceuticals Co, Ltd (China)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GeneScience Pharmaceuticals Co, Ltd (China)

    • Figure Sales and Growth Rate Analysis of GeneScience Pharmaceuticals Co, Ltd (China)

    • Figure Revenue and Market Share Analysis of GeneScience Pharmaceuticals Co, Ltd (China)

    • Table Product and Service Introduction of GeneScience Pharmaceuticals Co, Ltd (China)

    • Table Company Profile and Development Status of Genentech, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech, Inc (US)

    • Figure Sales and Growth Rate Analysis of Genentech, Inc (US)

    • Figure Revenue and Market Share Analysis of Genentech, Inc (US)

    • Table Product and Service Introduction of Genentech, Inc (US)

    • Table Company Profile and Development Status of Pfizer, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc (US)

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc (US)

    • Figure Revenue and Market Share Analysis of Pfizer, Inc (US)

    • Table Product and Service Introduction of Pfizer, Inc (US)

    • Table Company Profile and Development Status of Sandoz International GmbH (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International GmbH (Germany)

    • Figure Sales and Growth Rate Analysis of Sandoz International GmbH (Germany)

    • Figure Revenue and Market Share Analysis of Sandoz International GmbH (Germany)

    • Table Product and Service Introduction of Sandoz International GmbH (Germany)

    • Table Company Profile and Development Status of Eli Lilly and Company (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company (US)

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company (US)

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company (US)

    • Table Product and Service Introduction of Eli Lilly and Company (US)

    • Table Company Profile and Development Status of Merck KgaA (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KgaA (Germany)

    • Figure Sales and Growth Rate Analysis of Merck KgaA (Germany)

    • Figure Revenue and Market Share Analysis of Merck KgaA (Germany)

    • Table Product and Service Introduction of Merck KgaA (Germany)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.